|
|
|
Scientists are still in the process of evaluating a possible connection between two COVID-19 vaccines and blood clotting, a side effect that has so far appeared to be very rare. |
The CDC's Advisory Committee on Immunization Practices is examining the Johnson & Johnson vaccine Wednesday, one day after federal health officials recommended a pause on administering the shots because of blood clots reported in six people out of more than 6.8 million doses administered. |
The reported blood clotting is believed to be the same rare condition seen in Europe with a similar vaccine made by AstraZeneca and Oxford University, USA TODAY's Karen Weintraub reported. That vaccine, which has not been authorized in the U.S., has been linked to more than 220 unusual clotting cases as of April 4 out of 34 million doses delivered. |
Nonetheless, experts are urging Americans not to panic about the Johnson & Johnson pause while further examination of possible issues takes place. |
It's Wednesday, and this is Coronavirus Watch from the USA TODAY Network. Here's more news to know today, as of 1:30 p.m. EDT. |
|
FYI: We are working on some technical issues with the links in the newsletter. If the story you click does not load immediately, go check it out on the USA TODAY app or visit usatoday.com on your browser. |
Thanks for subscribing to Coronavirus Watch. Know someone looking for daily news updates right in their inbox? Forward this email along so they can sign up here. |
– Jay Cannon, USA TODAY Network and Wires Editor, @JayTCannon on Twitter. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|